Defining The RNA Therapeutics Industry In 2023

By Anna Rose Welch, Editorial & Community Director, Advancing RNA

Following the events of 2020 and 2021 in which mRNA vaccines burst onto the scene, RNA R&D professionals suddenly found themselves and the work they do catapulted into the spotlight. While they once toiled in near obscurity in resource-deprived labs, it’s now possible (albeit still slightly otherworldly) to attend conferences entirely devoted to the art of RNA process development and manufacturing.